Endovascular Today

Galaxy’s Pivotal Trial of SEAL Device for Brain Aneurysms Completes Enrollment

Galaxy Therapeutics announced it has completed enrollment in the SEAL IT pivotal trial evaluating the company’s saccular ...
Endovascular Today

CorMedix DefenCath Evaluated to Prevent Catheter-Related Bloodstream Infections in Hemodialysis

CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...
Endovascular Today

Management of PAD in Patients With Diabetes Addressed in ACC Scientific Statement

The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery dise ...
Endovascular Today

Shape Memory Medical’s Impede Embolization Plug Product Family Secures EU MDR Certification

Shape Memory Medical Inc. announced that its Impede embolization plug product family, which previously received CE Mark approv ...
Endovascular Today

4-NiVO Trial Begins for iVascular’s iNstroke 4F Thromboaspiration Catheter

December 22, 2025—iVascular announced the initiation of the 4-NiVO clinical study, which is evaluating the efficacy and safety of its iNstroke 4 ...
Endovascular Today

Bentley’s BeGraft Plus for BEVAR Plus Used in First Clinical Procedure

December 3, 2025—Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeGraft Plus, which features a new 77/78-mm length. On November ...
Endovascular Today

Bentley’s BeGraft Plus for BEVAR Receives CE Mark Approval

November 19, 2025—Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair (BEVAR), expanding Bentley’s ...
Endovascular Today

FORWARD PAD Results Presented for J&J’s Shockwave Javelin Peripheral IVL Catheter

November 11, 2025—Johnson & Johnson MedTech announced the 1-year results from the FORWARD PAD study of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a Forward IVL platform ...
Endovascular Today

PERFORMANCE III 30-Day Outcomes Reported for Contego Neuroguard TCAR-IEP System

November 3, 2025—Contego Medical announced 30-day outcomes from the PERFORMANCE III study evaluating the Neuroguard IEP system for direct transcarotid artery revascularization (TCAR-IEP). Among 146 ...
Endovascular Today

Long-Term SPYRAL HTN-ON MED Data Presented for Medtronic’s Symplicity Spyral RDN System

October 26, 2025—Medtronic announced that long-term results from its final report of the SPYRAL HTN-ON MED trial showed that patients treated with the company’s radiofrequency-based Symplicity Spyral ...
Endovascular Today

Antithrombogenic Indication Cleared for Access Vascular’s HydroMid and HydroPICC

October 22, 2025—Access Vascular, Inc. announced that the FDA cleared a new indication for its single-lumen Mimix HydroMid midline catheter and its single- and dual-lumen HydroPICC peripherally ...
Endovascular Today

Medtronic Commences Full Distribution of Contego Neuroguard IEP for Carotid Stenting in the United States

October 8, 2025—Medtronic announced full distribution in the United States of Contego Medical’s Neuroguard integrated embolic protection (IEP) system after conducting a limited market rollout. The ...